Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,775 | 1 | 69.2% |
| Food and Beverage | $1,237 | 33 | 30.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,907 | 2 | $0 (2019) |
| Medtronic USA, Inc. | $695.32 | 11 | $0 (2020) |
| LivaNova USA, Inc. | $78.04 | 3 | $0 (2018) |
| Cyberonics, Inc. | $39.11 | 1 | $0 (2017) |
| Nevro Corp. | $35.27 | 1 | $0 (2020) |
| Amgen Inc. | $27.46 | 1 | $0 (2021) |
| Medtronic, Inc. | $27.09 | 1 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $26.58 | 2 | $0 (2018) |
| HOSPIRA, INC. | $24.34 | 1 | $0 (2017) |
| Upsher-Smith Laboratories LLC | $23.68 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $108.67 | 6 | Amgen Inc. ($27.46) |
| 2020 | $178.54 | 4 | Medtronic USA, Inc. ($129.94) |
| 2019 | $3,062 | 4 | AstraZeneca Pharmaceuticals LP ($2,907) |
| 2018 | $155.98 | 5 | Medtronic USA, Inc. ($80.91) |
| 2017 | $507.45 | 15 | Medtronic USA, Inc. ($350.21) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/21/2021 | RedHill Biopharma Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Opioid Antagonist | ||||||
| 05/10/2021 | MDD US Operations, LLC | MYOBLOC (Drug), APOKYN | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: NEUROLOGY | ||||||
| 05/04/2021 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Sleep | ||||||
| 03/25/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: Neurology | ||||||
| 03/15/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: Neuroscience | ||||||
| 01/08/2021 | Medtronic, Inc. | Adaptix (Device) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: TL | ||||||
| 10/19/2020 | SI-BONE, Inc. | iFuse Implant (Device) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: sacroiliac joint dysfunction | ||||||
| 03/11/2020 | Medtronic USA, Inc. | RIALTO (Device) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: TL | ||||||
| 01/29/2020 | Medtronic USA, Inc. | O-ARM-Spine (Device) | Food and Beverage | In-kind items and services | $104.71 | General |
| Category: Enabling | ||||||
| 01/06/2020 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $35.27 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/07/2019 | Medtronic USA, Inc. | PIVOX Oblique Lateral Spinal System (Device) | Food and Beverage | In-kind items and services | $134.26 | General |
| Category: TL | ||||||
| 04/23/2019 | Siemens Medical Solutions USA, Inc. | Biograph mCT (Device) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: MI - Nuclear Medicine (incl. PETNET & MIBR) | ||||||
| 01/23/2019 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $2,775.00 | General |
| Category: Oncology | ||||||
| 01/11/2019 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $132.15 | General |
| Category: Oncology | ||||||
| 08/22/2018 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Neurology | ||||||
| 05/23/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug), ONZETRA Xsail | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 04/16/2018 | Medtronic USA, Inc. | O-ARM-Spine (Device) | Food and Beverage | In-kind items and services | $80.91 | General |
| Category: Enabling | ||||||
| 03/21/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: AED | ||||||
| 01/31/2018 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: VNS Therapy (Product Class) | ||||||
| 12/20/2017 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: VNS Therapy (Product Class) | ||||||
| 12/05/2017 | Upsher-Smith Laboratories LLC | QUDEXY XR Topiramate Extended Release Capsules (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Neurology | ||||||
| 11/01/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.39 | General |
| Category: AED | ||||||
| 10/06/2017 | Medtronic USA, Inc. | ATLANTIS (Device) | Food and Beverage | In-kind items and services | $50.79 | General |
| Category: Cervical | ||||||
| 10/03/2017 | Medtronic USA, Inc. | ATLANTIS (Device) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: Cervical | ||||||
| 09/20/2017 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: VNS Therapy (Product Class) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 3,000 | 3,405 | $1.7M | $91,043 |
| 2022 | 10 | 325 | 369 | $189,747 | $9,695 |
| 2021 | 7 | 211 | 216 | $36,227 | $10,244 |
| 2020 | 7 | 248 | 256 | $46,631 | $12,394 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 348 | 349 | $480,701 | $16,964 | 3.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 64 | 134 | $91,150 | $12,498 | 13.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,209 | 1,502 | $221,055 | $8,913 | 4.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 54 | $57,213 | $6,887 | 12.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 91 | 102 | $16,370 | $6,717 | 41.0% |
| 75572 | Ct scan of heart structure with contrast | Facility | 2023 | 71 | 71 | $110,991 | $4,233 | 3.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 65 | $28,880 | $4,026 | 13.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 43 | 43 | $27,449 | $3,899 | 14.2% |
| 75561 | Mri scan of heart before and after contrast | Facility | 2023 | 40 | 40 | $59,176 | $3,688 | 6.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 46 | 46 | $86,184 | $2,696 | 3.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 170 | 170 | $60,249 | $2,662 | 4.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 25 | 25 | $6,991 | $2,497 | 35.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $21,468 | $2,363 | 11.0% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Facility | 2023 | 31 | 31 | $14,965 | $2,078 | 13.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 170 | 170 | $89,903 | $1,752 | 1.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 84 | 85 | $46,615 | $1,623 | 3.5% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 69 | 69 | $43,662 | $1,240 | 2.8% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 23 | 23 | $33,954 | $1,183 | 3.5% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2023 | 13 | 13 | $28,012 | $987.91 | 3.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 11 | 11 | $23,931 | $834.00 | 3.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 21 | $6,255 | $822.36 | 13.1% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Facility | 2023 | 31 | 31 | $5,623 | $690.00 | 12.3% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 111 | 112 | $21,767 | $611.49 | 2.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 63 | 66 | $9,734 | $384.60 | 4.0% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 23 | 23 | $13,257 | $369.00 | 2.8% |
About Dr. David Min, MD
Dr. David Min, MD is a Cardiovascular Disease healthcare provider based in Lebanon, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205946126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Min, MD has received a total of $4,012 in payments from pharmaceutical and medical device companies, with $108.67 received in 2021. These payments were reported across 34 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($2,775).
As a Medicare-enrolled provider, Min has provided services to 3,784 Medicare beneficiaries, totaling 4,246 services with total Medicare billing of $123,376. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Lebanon, NH
- Active Since 08/30/2006
- Last Updated 12/15/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1205946126
Products in Payments
- CALQUENCE (Drug) $2,907
- O-ARM-Spine (Device) $185.62
- PIVOX Oblique Lateral Spinal System (Device) $134.26
- RIALTO (Device) $132.00
- VNS Therapy (Device) $117.15
- KYPHON Balloon Kyphoplasty (Device) $104.40
- ADAPTIVESTIM (Device) $66.77
- ATLANTIS (Device) $60.92
- Senza Spinal Cord Stimulation System (Device) $35.27
- Aimovig (Biological) $27.46
- Adaptix (Device) $27.09
- TROKENDI XR (Drug) $26.58
- PRECEDEX (Drug) $24.34
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $23.68
- Biograph mCT (Device) $20.43
- Briviact (Drug) $17.71
- Dayvigo (Drug) $14.65
- MYOBLOC (Drug) $14.07
- iFuse Implant (Device) $13.33
- Movantik (Drug) $12.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lebanon
Dr. Emily Zeitler, Md, MD
Cardiovascular Disease — Payments: $166,924
Andre Olivier, Md, MD
Cardiovascular Disease — Payments: $155,216
Robert Woods, M.d, M.D
Cardiovascular Disease — Payments: $64,184
Dr. Merle Myerson, Md, MD
Cardiovascular Disease — Payments: $48,844
Dr. Rajbir Sangha, Mb Chb, MB CHB
Cardiovascular Disease — Payments: $43,680
Dr. Samuel Kolman, Md, MD
Cardiovascular Disease — Payments: $35,366